Eravacycline monotherapy and combination therapy against KPC-2- and NDM-1-co- producing <i>Klebsiella pneumoniae</i>: <i>in vitro</i> and <i>in vivo</i> activity analysis. [PDF]
Zhao X +11 more
europepmc +1 more source
Crystal structure reveals the hydrophilic R1 group impairs NDM-1-ligand binding via water penetration at L3. [PDF]
Shi X +9 more
europepmc +1 more source
Clonal dissemination of carbapenem-resistant ST477 <i>Klebsiella michiganensis</i> co-producing NDM-1, SFO-1, and VEB-3 in a Chinese hospital. [PDF]
Liu H +7 more
europepmc +1 more source
Real-time qPCR analysis of genes expression in the carbapenem-resistant bacteria (Escherichia coli IMP-type and Klebsiella pneumoniae NDM-1) during biofilm formation. [PDF]
Al-Bayati, Majid, Samarasinghe, S.
core
Characterization of <i>Enterobacter cloacae complex</i> clinical isolates: comparative genomics and the role of the efflux pump AcrAB-TolC over-expression and NDM-1 production. [PDF]
Jiang N, Pu F, Wang W, Wang D, He J.
europepmc +1 more source
The extent of carbapenemase encoding genes in public genome sequences [PDF]
A Swart +6 more
core
International spread or local outbreak? Epidemiologic analyses of transmission patterns of NDM-1-producing <i>Klebsiella pneumoniae</i> based on genomic surveillance data, Germany, January 2022 to February 2023. [PDF]
Sandfort M +16 more
europepmc +1 more source
Computational Analysis of Novel NDM‑1 Inhibitors: Absorption, Distribution, Metabolism, Excretion, and Toxicity Evaluation, Molecular Docking, and Molecular Dynamics of Cyclic Borate Derivatives and Chromones. [PDF]
Valencia Cristancho E +3 more
europepmc +1 more source
Emergence of NDM-1- and OXA-23-Co-Producing <i>Acinetobacter baumannii</i> ST1 Isolates from a Burn Unit in Spain. [PDF]
Hidalgo E +8 more
europepmc +1 more source
Phylogenomic analysis of OXA-23-positive and genetic context of rare NDM-1-producing carbapenem-resistant <i>Acinetobacter baumannii</i> isolates in a teaching hospital in China. [PDF]
Dong S, Lou J, Mao C, Fang Y, Zhang H.
europepmc +1 more source

